It may be okay to drink alcohol while on Ozempic, but just know the combination could cause low blood sugar
Specific Populations No clinically significant differences in semaglutide pharmacokinetics were observed based on age (18 years old), sex, race (White, Asian or Black or African American), ethnicity, body weight (40 to 188 kg), upper GI disease (i.e., chronic gastritis and/or gastroesophageal reflux disease), hepatic impairment (i.e., mild, moderate, severe based on the Child-Pugh system) and renal impairment (i.e., mild, moderate, severe, end staged renal disease)
A 2023 study on tirzepatide found that participants who switched to a placebo after losing about 21% of their body weight in three years gained back about 14% over another year
Participants shed roughly 15% of their starting body weight on average, which is deemed clinically significant